Mumbai, India (CU)_ INTAS is the first pharmaceutical firm in India to introduce Oral Azacitidine. Patients with Acute Myeloid Leukemia will benefit from this progressive development, which will extend their survival time and enhance their quality of life. Intas Pharmaceuticals, one of India’s major pharmaceutical firms, is the first to offer Oral Azacitidine in India with the brand name Azadine-O, making therapy for Acute Myeloid Leukemia, which is a form of blood cancer, more accessible to patients.
Adult patients with Acute Myeloid Leukemia can use…
